{
    "organizations": [],
    "uuid": "dea05e75b81ee84e114bd8d094df5d29519a5f40",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-regeneron-reports-q4-adj-earnings/brief-regeneron-reports-q4-adj-earnings-per-share-5-23-idUSASB0C4PX",
    "ord_in_thread": 0,
    "title": "BRIEF-Regeneron Reports Q4 Adj. Earnings Per Share $5.23",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Regeneron Pharmaceuticals Inc:\n* REGENERON REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL AND OPERATING RESULTS\n* Q4 NON-GAAP EARNINGS PER SHARE $5.23 * Q4 GAAP EARNINGS PER SHARE $1.50 * REGENERON PHARMACEUTICALS - Q4 GAAP NET INCOME PER DILUTED SHARE INCLUDES CHARGE OF $2.82/DILUTED SHARE IN CONNECTION WITH U.S. TAX REFORM LEGISLATION\n* SEES, IN FY 2018, SANOFI COLLABORATION REVENUE OF $450 MILLION TO $500 MILLION\n* Q4 EYLEA (AFLIBERCEPT) INJECTION U.S. NET SALES INCREASED 14% TO $975 MILLION VERSUS Q4 2016\n* SEES FY 2018 CAPITAL EXPENDITURES OF $420 MILLION TO $500 MILLION\n* REGENERON PHARMA - TOTAL REVENUES, WHICH INCLUDE PRODUCT REVENUES , INCREASED BY 29% TO $1.582 BILLION IN Q4\n* Q4 EARNINGS PER SHARE VIEW $4.53, REVENUE VIEW $1.50 BILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T20:16:00.000+02:00",
    "crawled": "2018-02-08T14:28:31.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "regeneron",
        "pharmaceutical",
        "inc",
        "regeneron",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "operating",
        "result",
        "q4",
        "earnings",
        "per",
        "share",
        "q4",
        "gaap",
        "earnings",
        "per",
        "share",
        "regeneron",
        "pharmaceutical",
        "q4",
        "gaap",
        "net",
        "income",
        "per",
        "diluted",
        "share",
        "includes",
        "charge",
        "share",
        "connection",
        "tax",
        "reform",
        "legislation",
        "see",
        "fy",
        "sanofi",
        "collaboration",
        "revenue",
        "million",
        "million",
        "q4",
        "eylea",
        "aflibercept",
        "injection",
        "net",
        "sale",
        "increased",
        "million",
        "versus",
        "q4",
        "see",
        "fy",
        "capital",
        "expenditure",
        "million",
        "million",
        "regeneron",
        "pharma",
        "total",
        "revenue",
        "include",
        "product",
        "revenue",
        "increased",
        "billion",
        "q4",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}